Kavalactone

 ( Monoamine Oxidase Inhibitors ) 

Kavalactones are a class of lactone compounds found in kava roots and Alpinia zerumbet (shell ginger) and in several Gymnopilus, Phellinus and Inonotus fungi. Some kavalactones are bioactive. They are responsible for the psychoactive, analgesic, euphoric and sedative effects of kava.

---

Bioactivity Kava extract interacts with many pharmaceuticals and herbal medications. In human volunteers, in vivo inhibition includes CYP1A2 and CYP2E1 through use of probe drugs to measure inhibition.

---

Research Its anxiolytic and hepatotoxic properties have been investigated.

The major kavalactones (except for desmethoxyyangonin) potentiate GABAA receptor, which may underlie the anxiolytic and sedative properties of kava. Further, inhibition of the reuptake of norepinephrine and dopamine, binding to the CB₁ receptor, inhibition of voltage-gated sodium channel and calcium channels, and monoamine oxidase B reversible inhibition are additional pharmacological actions that have been reported for kavalactones.

---

Toxicity Several kavalactones (e.g., methysticin and yangonin) affect a group of involved in metabolism, called the CYP450 system. Hepatotoxicity occurred in a small portion of previously healthy kava users, particularly from extracts, as opposed to whole root powders.

---

Compounds

At least 18 different kavalactones are known, with methysticin being the first identified.

Multiple analogues, such as ethysticin, have also been isolated. Some consist of a substituted α-pyrone as the lactone, while others are partially saturated.

The average elimination half-life of kavalactones typically present in kava root is 9 hr.

Kavalactones>

Yangonin	1	-OCH3	-H	-H	-H
10-methoxyyangonin	1	-OCH3	-H	-OCH3	-H
11-methoxyyangonin	1	-OCH3	-OCH3	-H	-H
11-hydroxyyangonin	1	-OCH3	-OH	-H	-H
Desmethoxyyangonin	1	-H	-H	-H	-H
11-methoxy-12-hydroxydehydrokavain	1	-OH	-OCH3	-H	-H
7,8-dihydroyangonin	2	-OCH3	-H	-H	-H
Kavain	3	-H	-H	-H	-H
5-hydroxykavain	3	-H	-H	-H	-OH
5,6-dihydroyangonin	3	-OCH3	-H	-H	-H
7,8-dihydrokavain	4	-H	-H	-H	-H
5,6,7,8-tetrahydroyangonin	4	-OCH3	-H	-H	-H
5,6-dehydromethysticin	5	-O-CH2-O-		-H	-H
Methysticin	7	-O-CH2-O-		-H	-H
7,8-dihydromethysticin	8	-O-CH2-O-		-H	-H

---

Biosynthesis

The kavalactone biosynthetic pathway in Piper methysticum was described in 2019.

---

See also

• Pipermethystine

---

External links

• The great kava boom: how Fiji's beloved psychoactive brew is going global The Guardian, 2020

Categories: Monoamine Oxidase Inhibitors, Gabaa Receptor Positive Allosteric Modulators, Anxiolytics, Analgesics, Sedatives, Anticonvulsants, Nootropics

Post Comment